214 related articles for article (PubMed ID: 27544035)
1. Complications and Outcomes Associated With Surgical Management of Renal Cell Carcinoma Involving the Liver: A Matched Cohort Study.
Joyce DD; Psutka SP; Groeschl RT; Thompson RH; Boorjian SA; Cheville JC; Stewart-Merrill SB; Lohse CM; Costello BA; Que FG; Leibovich BC
Urology; 2017 Jan; 99():155-161. PubMed ID: 27544035
[TBL] [Abstract][Full Text] [Related]
2. Extended hepatic metastasectomy for renal cell carcinoma-new aspects in times of targeted therapy: a single-center experience over three decades.
Beetz O; Söffker R; Cammann S; Oldhafer F; Vondran FWR; Imkamp F; Klempnauer J; Kleine M
Langenbecks Arch Surg; 2020 Feb; 405(1):97-106. PubMed ID: 31938833
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Characterization of the Perioperative Morbidity of Cytoreductive Nephrectomy.
Gershman B; Moreira DM; Boorjian SA; Lohse CM; Cheville JC; Costello BA; Leibovich BC; Thompson RH
Eur Urol; 2016 Jan; 69(1):84-91. PubMed ID: 26044802
[TBL] [Abstract][Full Text] [Related]
4. Surgical morbidity associated with administration of targeted molecular therapies before cytoreductive nephrectomy or resection of locally recurrent renal cell carcinoma.
Margulis V; Matin SF; Tannir N; Tamboli P; Swanson DA; Jonasch E; Wood CG
J Urol; 2008 Jul; 180(1):94-8. PubMed ID: 18485389
[TBL] [Abstract][Full Text] [Related]
5. Multivisceral Resection for Locally Invasive Colorectal Liver Metastases: Outcomes of a Matched Cohort Analysis.
Hand F; Sanabria Mateos R; Durand M; Fennelly D; McDermott R; Maguire D; Geoghegan J; Winter D; Hoti E
Dig Surg; 2018; 35(6):514-519. PubMed ID: 29346790
[TBL] [Abstract][Full Text] [Related]
6. The Role of Metastasectomy in Patients with Renal Cell Carcinoma with Sarcomatoid Dedifferentiation: A Matched Controlled Analysis.
Thomas AZ; Adibi M; Slack RS; Borregales LD; Merrill MM; Tamboli P; Sircar K; Jonasch E; Tannir NM; Matin SF; Wood CG; Karam JA
J Urol; 2016 Sep; 196(3):678-84. PubMed ID: 27036304
[TBL] [Abstract][Full Text] [Related]
7. Higher perioperative morbidity and in-hospital mortality in patients with end-stage renal disease undergoing nephrectomy for non-metastatic kidney cancer: a population-based analysis.
Schmitges J; Trinh QD; Sun M; Hansen J; Bianchi M; Jeldres C; Perrotte P; Dahlem R; Shariat SF; Chun FK; Montorsi F; Menon M; Fisch M; Graefen M; Karakiewicz PI
BJU Int; 2012 Sep; 110(6 Pt B):E183-90. PubMed ID: 22321256
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of perioperative complications in open and laparoscopic surgery for renal cell cancer with tumor thrombus involvement using the Clavien-Dindo classification.
Ebbing J; Wiebach T; Kempkensteffen C; Miller K; Bachmann A; Günzel K; Rieken M; Friedersdorff F; Baumunk D; Weikert S
Eur J Surg Oncol; 2015 Jul; 41(7):941-52. PubMed ID: 25817982
[TBL] [Abstract][Full Text] [Related]
9. Complications After Metastasectomy for Renal Cell Carcinoma-A Population-based Assessment.
Meyer CP; Sun M; Karam JA; Leow JJ; de Velasco G; Pal SK; Chang SL; Trinh QD; Choueiri TK
Eur Urol; 2017 Aug; 72(2):171-174. PubMed ID: 28359734
[TBL] [Abstract][Full Text] [Related]
10. Solitary liver metastasis of chromophobe renal cell carcinoma 20 years after nephrectomy treated by hepatic resection.
Lordan JT; Fawcett WJ; Karanjia ND
Urology; 2008 Jul; 72(1):230.e5-6. PubMed ID: 18329075
[TBL] [Abstract][Full Text] [Related]
11. The influence of the primary tumor on the long-term results of pulmonary metastasectomy for metastatic renal cell carcinoma.
Bölükbas S; Kudelin N; Eberlein M; Fisseler-Eckhoff A; Schirren J
Thorac Cardiovasc Surg; 2012 Sep; 60(6):390-7. PubMed ID: 22207364
[TBL] [Abstract][Full Text] [Related]
12. Hepatic resection for metastatic renal tumors: is it worthwhile?
Alves A; Adam R; Majno P; Delvart V; Azoulay D; Castaing D; Bismuth H
Ann Surg Oncol; 2003 Jul; 10(6):705-10. PubMed ID: 12839857
[TBL] [Abstract][Full Text] [Related]
13. Surgical treatment of atypical metastasis from renal cell carcinoma (RCC).
Antonelli A; Arrighi N; Corti S; Legramanti S; Zanotelli T; Cozzoli A; Cunico SC; Simeone C
BJU Int; 2012 Dec; 110(11 Pt B):E559-63. PubMed ID: 22639956
[TBL] [Abstract][Full Text] [Related]
14. Preoperative metastatic status, level of thrombus and body mass index predict overall survival in patients undergoing nephrectomy and inferior vena cava thrombectomy.
Spiess PE; Kurian T; Lin HY; Rawal B; Kim T; Sexton WJ; Pow-Sang JM
BJU Int; 2012 Dec; 110(11 Pt B):E470-4. PubMed ID: 22519938
[TBL] [Abstract][Full Text] [Related]
15. Surgical Management of Local Retroperitoneal Recurrence of Renal Cell Carcinoma after Radical Nephrectomy.
Thomas AZ; Adibi M; Borregales LD; Hoang LN; Tamboli P; Jonasch E; Tannir NM; Matin SF; Wood CG; Karam JA
J Urol; 2015 Aug; 194(2):316-22. PubMed ID: 25758610
[TBL] [Abstract][Full Text] [Related]
16. Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy.
Itano NB; Blute ML; Spotts B; Zincke H
J Urol; 2000 Aug; 164(2):322-5. PubMed ID: 10893575
[TBL] [Abstract][Full Text] [Related]
17. A multi-institution analysis of outcomes of liver-directed surgery for metastatic renal cell cancer.
Hatzaras I; Gleisner AL; Pulitano C; Sandroussi C; Hirose K; Hyder O; Wolfgang CL; Aldrighetti L; Crawford M; Choti MA; Pawlik TM
HPB (Oxford); 2012 Aug; 14(8):532-8. PubMed ID: 22762401
[TBL] [Abstract][Full Text] [Related]
18. Surgical resection for management of renal cancer with hepatic involvement.
Bennett BC; Selby R; Bahnson RR
J Urol; 1995 Sep; 154(3):972-4. PubMed ID: 7637104
[TBL] [Abstract][Full Text] [Related]
19. Combined nephrectomy and major hepatectomy: indications, outcomes, and recommendations.
Yezhelyev M; Master V; Egnatashvili V; Kooby DA
J Am Coll Surg; 2009 Mar; 208(3):410-8. PubMed ID: 19318003
[TBL] [Abstract][Full Text] [Related]
20. Ablation versus Resection for Stage 1A Renal Cell Carcinoma: National Variation in Clinical Management and Selected Outcomes.
Uhlig J; Kokabi N; Xing M; Kim HS
Radiology; 2018 Sep; 288(3):889-897. PubMed ID: 29969077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
